Innovative Drugs To Treat Cancer on Money Info Show

Innovative Drugs To Treat Cancer

Innovative Drugs To Treat Cancer

Best Stocks To Buy August 2014

Medical Stock News

on Money Info Investment News Show

The show featured a live interview with

Rachel Levine, Vice President, Investor Relations

Cleveland BioLabs, Inc.

(NASDAQ Stock Symbol: CBLI)

Corporate Site:

Investors Conference Call Transcript — Click Here

Financials News – Click Here

Part 1 of the show:

Best Stocks To Buy August 2014 Undervalued Medical Stock News

Part 2 of the Show with CBLI Interview:

Innovative Drugs To Treat Cancer

Small Cap Medical Stock News

Developing and commercializing

innovative drugs to

treat cancer and orphan diseases and

protect healthy tissues.

Cleveland BioLabs, Inc. is an innovative biopharmaceutical company seeking to develop first-in-class pharmaceuticals designed to address diseases with significant medical need.

Small cap medical stocks

The company’s lead product candidates are Entolimod, which is being developed as radiation countermeasure and a potential cancer treatment and Curaxin CBL0137, our lead oncology product candidate.

CBL0137 is under development by Incuron, LLC, a Russian Federation based joint venture founded in 2010 between Russian Closed Mutual Venture Fund “Bioprocess Capital Ventures,” and Cleveland BioLabs.

undervalued healthcare stocks 2014

Cleveland BioLabs, Inc. conducts business in the United States and in the Russian Federation through its wholly and majority owned operating subsidiaries.

The company maintains strategicrelationships with the Cleveland Clinic, Roswell Park Cancer Institute, and the Children’s Cancer Institute Australia for Medical Research.

medical stocks to buy in 2014

To learn more about Cleveland BioLabs, Inc. 

visit the Company’s website at

To learn more about Incuron, LLC

visit the company’s website at

Medical Stocks To Buy

See more at Yahoo Finance Small Cap Medical Stock News

small cap stocks to buy

Medical Stocks In The News

Cleveland BioLabs Reduces Debt With $3.5 Million At-the-Market Private Placement of Unregistered Stock

(Marketwired – Jun 18, 2014) – Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it entered into a securities purchase agreement (the “Purchase Agreement”) with Dr. Mikhail Mogutov, Chairman of the Board of Directors of Incuron, LLC and Chairman of the Investment Committee and founder of Bioprocess Capital Ventures and one institutional investor (the “Investors”), to issue and sell in a private placement $3.5 million worth of the Company’s common stock, par value $.005 per share (the “Common Stock”),and warrants to purchase Common Stock.

See More

Yakov Kogan, Ph.D., MBA, Chief Executive Officer, stated, “This transaction deepens our strategic relationship with Dr. Mogutov. We appreciate his continued support of our science and development pipeline. These proceeds enable us to reduce the debt on our balance sheet by two-thirds, favorably impacting our cash runway.”

medical stocks to buy now

Money Info

Small cap stocks to buy

The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.

Money Info is hosted by Mike King and Charles Moskowitz.

Innovative Drugs To Treat Cancer

on Money Info Show